Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants
McGill University
$59,942.00
Validation of epigenetic markers in cervical carcinogenesis
FY 2018-19
Summary
Cervical cancer is caused by human papillomavirus (HPV) infection and is the result of progression from premalignant lesions to invasive cancer. Other than knowledge of the HPV type and patient’s age, which provide incomplete prediction, there is little that can help clinicians in managing patients with cervical pre-cancer. Our previous research found that epigenetic changes (not changes in the DNA, they are simply changes on how genes are expressed) are necessary for a cervical precancerous lesion to develop into cervical cancer. We recently discovered several markers that are associated with progression from pre-cancer to cancer. We propose to validate these markers in a different study population. If the association is confirmed, the biomarkers we discovered can be used as diagnostic tools to determine which women need to be followed-up or treated more aggressively in order to prevent precancerous cells developing into cervical cancer.
Department
Program
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
407426
Name
Franco Eduardo L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Validation of epigenetic markers in cervical carcinogenesis
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$59,942
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Environment Cancer
Abstract
Cervical cancer is caused by human papillomavirus (HPV) infection and is the result of progression from premalignant lesions to invasive cancer. Other than knowledge of the HPV type and patient’s age, which provide incomplete prediction, there is little that can help clinicians in managing patients with cervical pre-cancer. Our previous research found that epigenetic changes (not changes in the DNA, they are simply changes on how genes are expressed) are necessary for a cervical precancerous lesion to develop into cervical cancer. We recently discovered several markers that are associated with progression from pre-cancer to cancer. We propose to validate these markers in a different study population. If the association is confirmed, the biomarkers we discovered can be used as diagnostic tools to determine which women need to be followed-up or treated more aggressively in order to prevent precancerous cells developing into cervical cancer.
Competitiondate
201902
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Franco, Eduardo L
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $59,942~ $0~